Nisa Investment Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AVXL
VCM
SF
VPM
Nisa Investment Advisors's AVXL Position: Q1 2026 in Review
Nisa Investment Advisors increased its Anavex Life Sciences (AVXL) stake by 23% in Q1 2026, buying an estimated $321 and bringing the position to 394 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #2713.
Nisa Investment Advisors first reported a position in AVXL in Q2 2021 and has held it in 19 quarters since. The position peaked at $24.3K in Q4 2024. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.
- Nisa Investment Advisors held 394 shares of Anavex Life Sciences worth $1.21K as of Q1 2026.
- Nisa Investment Advisors bought 74 Anavex Life Sciences shares in Q1 2026, an estimated $321.
- Anavex Life Sciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2713 holding.
- Nisa Investment Advisors first reported a position in Anavex Life Sciences in Q2 2021 and has held it in 19 quarters since.
- Nisa Investment Advisors's Anavex Life Sciences position peaked at $24.3K in Q4 2024.
- 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.